当前位置：
主页产品
详情

Hexakis-O-(trimethylsilyl)inositol | CAS:2582-79-8

Hexakis-O-(trimethylsilyl)inositol

名称：六-O-(三甲基硅烷基)肌醇 | Hexakis-O-(trimethylsilyl)inositol
CAS号：2582-79-8
别名：
分子式：C₂₄H₆₀O₆Si₆
分子量：613.24
EINESC号：

产品描述

物理化学性质

密度	0.93±0.1 g/cm3 (20 ºC

安全数据

没有数据	没有数据

SDS

来源	SDS样本
没有数据	没有数据

产品合成路线

名称	CAS号

文章

同行评议文献

FOXC1 Regulates Expression of Prostaglandin Receptors Leading to an Attenuated Response to Latanoprost.Lance P Doucette et al.Investigative ophthalmology & visual science, 59(6), 2548-2554 (2018-05-31) Effect of prostaglandins A(2), E(1), F(2 alpha)and latanoprost on cultured human iridal melanocytes.D N Hu et al.Experimental eye research, 70(1), 113-120 (2000-01-25) Increased human scleral permeability with prostaglandin exposure.J W Kim et al.Investigative ophthalmology & visual science, 42(7), 1514-1521 (2001-05-31) Rapid metabolic responses to prostaglandins in cultured cells expressing the FP-receptor.E Walum et al.Advances in experimental medicine and biology, 407, 231-236 (1997-01-01) Prostaglandins increase matrix metalloproteinase release from human ciliary smooth muscle cells.R N Weinreb et al.Investigative ophthalmology & visual science, 38(13), 2772-2780 (1998-01-07) New prostaglandin analog formulation for glaucoma treatment containing cyclodextrins for improved stability, solubility and ocular tolerance.Marta Rodriguez-Aller et al.European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 95(Pt B), 203-214 (2015-05-12) Latanoprost and matrix metalloproteinase-1 in human choroid organ cultures.N Wang et al.Current eye research, 22(3), 198-207 (2001-07-20)

备注

Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.

Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1).

名称	CAS号

产品描述

物理化学性质

安全数据

SDS

相关产品

相关资讯